跳至主要内容
临床试验/NCT06553911
NCT06553911招募中不适用

Exploring the Application Efficacy of Artificial Intelligence (AI) Diagnostic Tools in Medical Imaging (MI) of Respiratory(R) Infectious (I) Disease (D)

Huashan Hospital1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2022年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
2,000
试验地点
1
主要终点
Evaluating the Diagnostic Efficacy of Artificial Intelligence Diagnostic Tools in Medical Imaging of Respiratory Infectious Diseases

研究概览

简要总结

The early identification and severe warning of acute respiratory infectious diseases are of paramount importance. Utilizing effective means to make correct diagnoses of the source of infection at an early stage is the premise of all effective measures. AI-MID is a research initiative that uses artificial intelligence tools to assist in the clinical medical imaging diagnosis of respiratory diseases, aiming to reduce the time doctors spend reviewing images, increase work efficiency, and enhance the sensitivity and specificity of pneumonia detection, thereby improving the detection rate of pneumonia at the grassroots level. This approach facilitates precise prevention, accurate diagnosis, and precise treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
1 Year 至 90 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 1-90 years old, gender not specified.
  • Exhibits symptoms of respiratory tract infection
  • Must have etiological examination results
  • Must have imaging data;

排除标准

  • Severe artifacts in medical images
  • Clinical diagnosis indicates concurrent pulmonary edema
  • Dual review results in unclear diagnosis or potential misdiagnosis
  • Other situations that may cause difficulties in reading the films, or as determined by the researcher, the study participant is deemed unsuitable for enrollment.

结局指标

主要结局

Evaluating the Diagnostic Efficacy of Artificial Intelligence Diagnostic Tools in Medical Imaging of Respiratory Infectious Diseases

时间窗: 2 years

To evaluate the diagnostic efficacy of computer-aided detection (CAD) software in the identification of pulmonary infections, the study will employ the following methods: Imaging Criteria: Experienced radiologists will interpret the medical imaging of study participants, serving as the imaging standard. Computer-Aided Detection: Concurrently, the CAD software will analyze the participants' medical imaging to generate diagnostic results. Efficacy Assessment: The accuracy and consistency of the CAD software will be evaluated by comparing its interpretations with the diagnoses made by the radiologists.

次要结局

  • Utilizing artificial intelligence tools for early identification and severe warning of respiratory infectious diseases(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wen-hong Zhang

Director of Division of Infectious Diseases

Huashan Hospital

研究点 (1)

Loading locations...

相似试验